𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines

✍ Scribed by Adriano Angelucci; Marianna Mari; Danilo Millimaggi; Ilaria Giusti; Gaspare Carta; Mauro Bologna; Vincenza Dolo

Book ID
113962586
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
842 KB
Volume
119
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The histone deacetylase inhibitor, suber
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
✍ Lisa M. Butler; Vasilios Liapis; Stelios Bouralexis; Katie Welldon; Shelley Hay; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 958 KB

## Abstract While the apoptosis‐inducing ligand Apo2L/TRAIL is a promising new agent for the treatment of cancer, the sensitivity of cancer cells for induction of apoptosis by Apo2L/TRAIL varies considerably. Identification of agents that can be used in combination with Apo2L/TRAIL to enhance apopt